Related Experiment Videos
Wound treatment with human skin equivalent.
Sumit K De1, Ernane D Reis, Morris D Kerstein
1University of Michigan Medical School, Ann Arbor, MI, USA.
Journal of the American Podiatric Medical Association
|January 18, 2002
Summary
Apligraf, a tissue-engineered skin graft, offers a safe and effective option for chronic wound healing. This skin equivalent, derived from neonatal foreskin, is easily accessible and shows minimal immune response, making it a viable alternative to traditional grafts.
Area of Science:
- Regenerative Medicine
- Tissue Engineering
- Dermatology
Background:
- Skin grafting is a common treatment for chronic wounds.
- Autografts and allografts are traditional methods.
- Alternative grafting options are needed for complex wounds.
Purpose of the Study:
- To evaluate Apligraf as a treatment for chronic wounds.
- To compare Apligraf to traditional skin grafts.
- To assess the safety and efficacy of Apligraf.
Main Methods:
- Apligraf, a bilayered human skin equivalent, was used for grafting.
- The skin equivalent is derived from neonatal foreskin.
- Immunoreactivity and accessibility were assessed.
Main Results:
- Apligraf demonstrated safety and effectiveness in wound closure.
- The tissue-engineered skin possesses epidermis and dermis similar to native skin.
- Apligraf showed low immunoreactivity and good accessibility.
Conclusions:
- Apligraf is a safe and effective alternative for chronic wound treatment.
- Its structural similarity to human skin contributes to its efficacy.
- Apligraf presents a valuable option for patients with diabetic, venous, and pressure ulcers.